The effect of tiotropium bromide on health-related quality of life in chronic obstructive pulmonary disease

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Tiotropium bromide is a once-daily anticholinergic recommended for maintenance treatment of chronic obstructive pulmonary disease. The 24-h bronchodilation in patients with chronic obstructive pulmonary disease achieved with tiotropium treatment is currently unique. However, there is an increasing demand for proven efficacy in parameters of more direct interest to patients, in addition to physiological parameters. This article reviews the data currently available on the efficacy of tiotropium to improve the health-related quality of life of patients with chronic obstructive pulmonary disease.
Original languageEnglish
Pages (from-to)391-405
Number of pages15
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume6
Issue number4
DOIs
Publication statusPublished - 1 Aug 2006

Fingerprint Dive into the research topics of 'The effect of tiotropium bromide on health-related quality of life in chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this